Ondansetron 2mg/ml Solution for Injection
*Company:
Baxter Holding B.V.Status:
No Recent UpdateLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 03 August 2023
File name
1400008305_IE_Ondansetron.pdf
Reasons for updating
- New PIL for new product
Updated on 26 January 2023
File name
ie-spc-2022-02-ondansetron 2mg-var031-c.pdf
Reasons for updating
- Document format updated
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 04 April 2022
File name
ie-spc-2022-02-ondan-var031-c.pdf
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to Section 4.8 – Undesirable effects - how to report a side effect
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 24 June 2020
File name
ie_spc_Ondansetron 2mg_PA2299-037-001_Dec 2019.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)